| Year |
Citation |
Score |
| 2021 |
Pittig A, Heinig I, Goerigk S, Thiel F, Hummel K, Scholl L, Deckert J, Pauli P, Domschke K, Lueken U, Fydrich T, Fehm L, Plag J, Ströhle A, Kircher T, ... ... Richter J, et al. Efficacy of temporally intensified exposure for anxiety disorders: A multicenter randomized clinical trial. Depression and Anxiety. PMID 34293223 DOI: 10.1002/da.23204 |
0.313 |
|
| 2021 |
Duits P, Baas JMP, Engelhard IM, Richter J, Huisman-van Dijk HM, Limberg-Thiesen A, Heitland I, Hamm AO, Cath DC. Latent class growth analyses reveal overrepresentation of dysfunctional fear conditioning trajectories in patients with anxiety-related disorders compared to controls. Journal of Anxiety Disorders. 78: 102361. PMID 33508747 DOI: 10.1016/j.janxdis.2021.102361 |
0.322 |
|
| 2021 |
Schiele MA, Reif A, Lin J, Alpers GW, Andersson E, Andersson G, Arolt V, Bergström J, Carlbring P, Eley TC, Esquivel G, Furmark T, Gerlach AL, Hamm A, Helbig-Lang S, ... ... Richter J, et al. Therapygenetic effects of 5-HTTLPR on cognitive-behavioral therapy in anxiety disorders: A meta-analysis. European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology. PMID 33483252 DOI: 10.1016/j.euroneuro.2021.01.004 |
0.349 |
|
| 2020 |
Hollandt M, Wroblewski A, Yang Y, Ridderbusch IC, Kircher T, Hamm AO, Straube B, Richter J. Facilitating translational science in anxiety disorders by adjusting extinction training in the laboratory to exposure-based therapy procedures. Translational Psychiatry. 10: 110. PMID 32317621 DOI: 10.1038/S41398-020-0786-X |
0.37 |
|
| 2020 |
Szeska C, Richter J, Wendt J, Weymar M, Hamm AO. Promoting long-term inhibition of human fear responses by non-invasive transcutaneous vagus nerve stimulation during extinction training. Scientific Reports. 10: 1529. PMID 32001763 DOI: 10.1038/S41598-020-58412-W |
0.352 |
|
| 2019 |
Yang Y, Lueken U, Richter J, Hamm A, Wittmann A, Konrad C, Ströhle A, Pfleiderer B, Herrmann MJ, Lang T, Lotze M, Deckert J, Arolt V, Wittchen HU, Straube B, et al. Effect of CBT on Biased Semantic Network in Panic Disorder: A Multicenter fMRI Study Using Semantic Priming. The American Journal of Psychiatry. appiajp201919020202. PMID 31838872 DOI: 10.1176/Appi.Ajp.2019.19020202 |
0.396 |
|
| 2019 |
Ridderbusch IC, Richter J, Yang Y, Hoefler M, Weber H, Reif A, Hamm A, Pané-Farré CA, Gerlach AL, Stroehle A, Pfleiderer B, Arolt V, Wittchen HU, Gloster A, Lang T, et al. Association of rs7688285 allelic variation coding for GLRB with fear reactivity and exposure-based therapy in patients with panic disorder and agoraphobia. European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology. PMID 31444036 DOI: 10.1016/J.Euroneuro.2019.07.133 |
0.417 |
|
| 2019 |
Gottschalk MG, Richter J, Ziegler C, Schiele MA, Mann J, Geiger MJ, Schartner C, Homola GA, Alpers GW, Büchel C, Fehm L, Fydrich T, Gerlach AL, Gloster AT, Helbig-Lang S, et al. Orexin in the anxiety spectrum: association of a HCRTR1 polymorphism with panic disorder/agoraphobia, CBT treatment response and fear-related intermediate phenotypes. Translational Psychiatry. 9: 75. PMID 30718541 DOI: 10.1038/S41398-019-0415-8 |
0.402 |
|
| 2019 |
Weber H, Deckert J, Lueken U, Kuhn M, Villmann C, Richter J, Straube B, Gajewska A, Andreatta M, Arias-Vasquez A, Hommers L, Kent L, Lonsdorf T, Pauli P, Reif A. ALLELIC VARIATION IN GLRB PREDISPOSES TO AGORAPHOBIA BY INCREASING STARTLE RESPONSE AND MODULATING DEFENSIVE REACTIVITY European Neuropsychopharmacology. 29: S959-S960. DOI: 10.1016/J.Euroneuro.2017.08.317 |
0.392 |
|
| 2018 |
Hommers LG, Richter J, Yang Y, Raab A, Baumann C, Lang K, Schiele MA, Weber H, Wittmann A, Wolf C, Alpers GW, Arolt V, Domschke K, Fehm L, Fydrich T, et al. A functional genetic variation of SLC6A2 repressor hsa-miR-579-3p upregulates sympathetic noradrenergic processes of fear and anxiety. Translational Psychiatry. 8: 226. PMID 30341278 DOI: 10.1038/S41398-018-0278-4 |
0.357 |
|
| 2018 |
Lang PJ, Herring DR, Duncan C, Richter J, Sege CT, Weymar M, Limberg-Thiesen A, Hamm AO, Bradley MM. The Startle-Evoked Potential: Negative Affect and Severity of Pathology in Anxiety/Mood Disorders. Biological Psychiatry. Cognitive Neuroscience and Neuroimaging. 3: 626-634. PMID 30047478 DOI: 10.1016/J.Bpsc.2017.07.006 |
0.383 |
|
| 2018 |
Wendt J, Hamm AO, Pané-Farré CA, Thayer JF, Gerlach A, Gloster AT, Lang T, Helbig-Lang S, Pauli P, Fydrich T, Ströhle A, Kircher T, Arolt V, Deckert J, Wittchen HU, ... Richter J, et al. Pretreatment Cardiac Vagal Tone Predicts Dropout from and Residual Symptoms after Exposure Therapy in Patients with Panic Disorder and Agoraphobia. Psychotherapy and Psychosomatics. PMID 29533952 DOI: 10.1159/000487599 |
0.341 |
|
| 2017 |
Trautmann S, Richter J, Muehlhan M, Höfler M, Wittchen HU, Domschke K, Ströhle A, Hamm AO, Weber H, Kircher T, Arolt V, Gerlach AL, Alpers GW, Fydrich T, Lang T, et al. Does prior traumatization affect the treatment outcome of CBT for panic disorder? The potential role of the MAOA gene and depression symptoms. European Archives of Psychiatry and Clinical Neuroscience. PMID 28712090 DOI: 10.1007/S00406-017-0823-9 |
0.398 |
|
| 2017 |
Duits P, Richter J, Baas JMP, Engelhard IM, Limberg-Thiesen A, Heitland I, Hamm AO, Cath DC. Enhancing effects of contingency instructions on fear acquisition and extinction in anxiety disorders Journal of Abnormal Psychology. 126: 378-391. PMID 28414478 DOI: 10.1037/Abn0000266 |
0.41 |
|
| 2017 |
Heinig I, Pittig A, Richter J, Hummel K, Alt I, Dickhöver K, Gamer J, Hollandt M, Koelkebeck K, Maenz A, Tennie S, Totzeck C, Yang Y, Arolt V, Deckert J, et al. Optimizing exposure-based CBT for anxiety disorders via enhanced extinction: Design and methods of a multicentre randomized clinical trial. International Journal of Methods in Psychiatric Research. PMID 28322476 DOI: 10.1002/Mpr.1560 |
0.41 |
|
| 2017 |
Lonsdorf TB, Menz MM, Andreatta M, Fullana MA, Golkar A, Haaker J, Heitland I, Hermann A, Kuhn M, Kruse O, Drexler SM, Meulders A, Nees F, Pittig A, Richter J, et al. Don't fear 'fear conditioning': Methodological considerations for the design and analysis of studies on human fear acquisition, extinction, and return of fear. Neuroscience and Biobehavioral Reviews. PMID 28263758 DOI: 10.1016/J.Neubiorev.2017.02.026 |
0.32 |
|
| 2017 |
Deckert J, Weber H, Villmann C, Lonsdorf TB, Richter J, Andreatta M, Arias-Vasquez A, Hommers L, Kent L, Schartner C, Cichon S, Wolf C, Schaefer N, von Collenberg CR, Wachter B, et al. GLRB allelic variation associated with agoraphobic cognitions, increased startle response and fear network activation: a potential neurogenetic pathway to panic disorder. Molecular Psychiatry. PMID 28167838 DOI: 10.1038/Mp.2017.2 |
0.384 |
|
| 2017 |
Domschke K, Ziegler C, Richter J, Mahr M, Gajewska A, Lang T, Pauli P, Rief W, Kircher T, Arolt V, Hamm AO, Deckert J. From candidate gene to (epi)genome-wide analysis of therapy response in adult anxiety disorders European Neuropsychopharmacology. 27. DOI: 10.1016/S0924-977X(17)31015-5 |
0.342 |
|
| 2016 |
Lueken U, Zierhut KC, Hahn T, Straube B, Kircher T, Reif A, Richter J, Hamm A, Wittchen HU, Domschke K. Neurobiological markers predicting treatment response in anxiety disorders: A systematic review and implications for clinical application. Neuroscience and Biobehavioral Reviews. PMID 27168345 DOI: 10.1016/J.Neubiorev.2016.04.005 |
0.401 |
|
| 2016 |
Ziegler C, Richter J, Mahr M, Gajewska A, Schiele MA, Gehrmann A, Schmidt B, Lesch KP, Lang T, Helbig-Lang S, Pauli P, Kircher T, Reif A, Rief W, Vossbeck-Elsebusch AN, et al. MAOA gene hypomethylation in panic disorder-reversibility of an epigenetic risk pattern by psychotherapy. Translational Psychiatry. 6: e773. PMID 27045843 DOI: 10.1038/Tp.2016.41 |
0.353 |
|
| 2016 |
Hamm AO, Richter J, Pané-Farré C, Westphal D, Wittchen HU, Vossbeck-Elsebusch AN, Gerlach AL, Gloster AT, Ströhle A, Lang T, Kircher T, Gerdes AB, Alpers GW, Reif A, Deckert J. Panic disorder with agoraphobia from a behavioral neuroscience perspective: Applying the research principles formulated by the Research Domain Criteria (RDoC) initiative. Psychophysiology. 53: 312-22. PMID 26877119 DOI: 10.1111/Psyp.12553 |
0.431 |
|
| 2016 |
Ziegler C, Richter J, Mahr M, Gajewska A, Schiele MA, Lang T, Pauli P, Reif A, Rief W, Kircher T, Arolt V, Hamm AO, Deckert J, Domschke K. Monoamine oxidase A (MAOA) gene hypomethylation in panic disorder − an epigenetic risk pattern reversed by psychotherapy? European Neuropsychopharmacology. 26. DOI: 10.1016/S0924-977X(16)30990-7 |
0.319 |
|
| 2015 |
Weber H, Richter J, Straube B, Lueken U, Domschke K, Schartner C, Klauke B, Baumann C, Pané-Farré C, Jacob CP, Scholz CJ, Zwanzger P, Lang T, Fehm L, Jansen A, et al. Allelic variation in CRHR1 predisposes to panic disorder: evidence for biased fear processing. Molecular Psychiatry. PMID 26324098 DOI: 10.1038/Mp.2015.125 |
0.413 |
|
| 2015 |
Hohoff C, Weber H, Richter J, Domschke K, Zwanzger PM, Ohrmann P, Bauer J, Suslow T, Kugel H, Baumann C, Klauke B, Jacob CP, Fritze J, Bandelow B, Gloster AT, et al. RGS2 ggenetic variation: association analysis with panic disorder and dimensional as well as intermediate phenotypes of anxiety. American Journal of Medical Genetics. Part B, Neuropsychiatric Genetics : the Official Publication of the International Society of Psychiatric Genetics. 168: 211-22. PMID 25740197 DOI: 10.1002/Ajmg.B.32299 |
0.367 |
|
| 2015 |
Drenckhan I, Glöckner-Rist A, Rist F, Richter J, Gloster AT, Fehm L, Lang T, Alpers GW, Hamm AO, Fydrich T, Kircher T, Arolt V, Deckert J, Ströhle A, Wittchen HU, et al. Dimensional structure of bodily panic attack symptoms and their specific connections to panic cognitions, anxiety sensitivity and claustrophobic fears. Psychological Medicine. 45: 1675-85. PMID 25482960 DOI: 10.1017/S0033291714002803 |
0.345 |
|
| 2014 |
Straube B, Reif A, Richter J, Lueken U, Weber H, Arolt V, Jansen A, Zwanzger P, Domschke K, Pauli P, Konrad C, Gerlach AL, Lang T, Fydrich T, Alpers GW, et al. The functional -1019C/G HTR1A polymorphism and mechanisms of fear. Translational Psychiatry. 4: e490. PMID 25514753 DOI: 10.1038/Tp.2014.130 |
0.444 |
|
| 2014 |
Helbig-Lang S, Richter J, Lang T, Gerlach AL, Fehm L, Alpers GW, Ströhle A, Kircher T, Deckert J, Gloster AT, Wittchen HU. The role of safety behaviors in exposure-based treatment for panic disorder and agoraphobia: associations to symptom severity, treatment course, and outcome. Journal of Anxiety Disorders. 28: 836-44. PMID 25445073 DOI: 10.1016/J.Janxdis.2014.09.010 |
0.331 |
|
| 2014 |
Hamm AO, Richter J, Pané-Farré CA. When the threat comes from inside the body: a neuroscience based learning perspective of the etiology of panic disorder. Restorative Neurology and Neuroscience. 32: 79-93. PMID 23803388 DOI: 10.3233/Rnn-139011 |
0.388 |
|
| 2014 |
Reif A, Richter J, Straube B, Höfler M, Lueken U, Gloster AT, Weber H, Domschke K, Fehm L, Ströhle A, Jansen A, Gerlach A, Pyka M, Reinhardt I, Konrad C, et al. MAOA and mechanisms of panic disorder revisited: from bench to molecular psychotherapy. Molecular Psychiatry. 19: 122-8. PMID 23319006 DOI: 10.1038/Mp.2012.172 |
0.443 |
|
| 2014 |
Hauke C, Gloster AT, Gerlach A, Richter J, Kircher T, Fehm L, Stoy M, Lang T, Klotsche J, Einsle F, Deckert J, Wittchen H. Standardized treatment manuals: does adherence matter? Sensoria: a Journal of Mind, Brain and Culture. 10: 1-13. DOI: 10.7790/Sa.V0I0.362 |
0.332 |
|
| 2012 |
Richter J, Hamm AO, Pané-Farré CA, Gerlach AL, Gloster AT, Wittchen HU, Lang T, Alpers GW, Helbig-Lang S, Deckert J, Fydrich T, Fehm L, Ströhle A, Kircher T, Arolt V. Dynamics of defensive reactivity in patients with panic disorder and agoraphobia: implications for the etiology of panic disorder. Biological Psychiatry. 72: 512-20. PMID 22621998 DOI: 10.1016/J.Biopsych.2012.03.035 |
0.41 |
|
| 2012 |
Emmrich A, Beesdo-Baum K, Gloster AT, Knappe S, Höfler M, Arolt V, Deckert J, Gerlach AL, Hamm A, Kircher T, Lang T, Richter J, Ströhle A, Zwanzger P, Wittchen HU. Depression does not affect the treatment outcome of CBT for panic and agoraphobia: results from a multicenter randomized trial. Psychotherapy and Psychosomatics. 81: 161-72. PMID 22399019 DOI: 10.1159/000335246 |
0.362 |
|
| 2012 |
Lang T, Helbig-Lang S, Gloster AT, Richter J, Hamm AO, Fehm L, Fydrich T, Gerlach AL, Ströhle A, Alpers GW, Gauggel S, Kircher T, Deckert J, Höfler M, Arolt V, et al. Effects of therapist-guided exposure in CBT for panic disorder and agoraphobia | Effekte therapeutenbegleiteter versus patientengeleiteter Exposition bei Panikstörung mit Agoraphobie Zeitschrift Fur Klinische Psychologie Und Psychotherapie. 41: 114-124. DOI: 10.1026/1616-3443/A000139 |
0.325 |
|
| 2012 |
Emmrich A, Beesdo-Baum K, Gloster AT, Knappe S, Hofler M, Deckert J, Gerlach AL, Lang T, Richter J, Wittchen HU. P.4.a.014 The role of depression in the treatment outcomes of a multicenter randomized trial of CBT for panic disorder and agoraphobia European Neuropsychopharmacology. 22. DOI: 10.1016/S0924-977X(12)70566-7 |
0.333 |
|
| 2011 |
Gloster AT, Wittchen HU, Einsle F, Lang T, Helbig-Lang S, Fydrich T, Fehm L, Hamm AO, Richter J, Alpers GW, Alpers GW, Gerlach AL, Ströhle A, Kircher T, Deckert J, et al. Psychological treatment for panic disorder with agoraphobia: a randomized controlled trial to examine the role of therapist-guided exposure in situ in CBT. Journal of Consulting and Clinical Psychology. 79: 406-20. PMID 21534651 DOI: 10.1037/A0023584 |
0.41 |
|
| 2011 |
Domschke K, Reif A, Weber H, Richter J, Hohoff C, Ohrmann P, Pedersen A, Bauer J, Suslow T, Kugel H, Heindel W, Baumann C, Klauke B, Jacob C, Maier W, et al. Neuropeptide S receptor gene -- converging evidence for a role in panic disorder. Molecular Psychiatry. 16: 938-48. PMID 20603625 DOI: 10.1038/Mp.2010.81 |
0.434 |
|
| 2011 |
Gloster AT, Wittchen H, Einsle F, Lang T, Helbig-Lang S, Fydrich T, Fehm L, Hamm AO, Richter J, Alpers GW, Gerlach AL, Ströhle A, Kircher T, Deckert J, Zwanzger P, et al. "Psychological treatment for panic disorder with agoraphobia: A randomized controlled trial to examine the role of therapist-guided exposure in situ in CBT": Correction to Gloster et al. (2011). Journal of Consulting and Clinical Psychology. 79: 652-652. DOI: 10.1037/A0025224 |
0.334 |
|
| 2009 |
Gloster AT, Wittchen HU, Einsle F, Höfler M, Lang T, Helbig-Lang S, Fydrich T, Fehm L, Hamm AO, Richter J, Alpers GW, Gerlach AL, Ströhle A, Kircher T, Deckert J, et al. Mechanism of action in CBT (MAC): methods of a multi-center randomized controlled trial in 369 patients with panic disorder and agoraphobia. European Archives of Psychiatry and Clinical Neuroscience. 259: S155-66. PMID 19876674 DOI: 10.1007/S00406-009-0065-6 |
0.416 |
|
| Show low-probability matches. |